Stock index futures were largely flat on Wednesday, a day after Wall Street witnessed a sell-off as the AI-tech rally halted ...

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

A triad of growth drivers and a long track record of operational excellence will ensure this company's admittance into an ...

While the stock is no longer the absolute bargain it was at the beginning of the year, it's still attractively valued. The stock trades at a forward price-to-earnings ratio (P/E) of around 27 times ...

So this is a good time of year to run stock screens.